ambrisentan

Poland

Drugs containing this active substance

  • AMBRISENTAN ACCORD

    This medicine is used to treat pulmonary arterial hypertension (PAH) in adults, adolescents, and children aged 8 years and older. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and relieves symptoms such as shortness of breath, fatigue, or dizziness.

    Form: tablets, film-coated

    Active substance Dosage
    ambrisentan 5 mg

    ATC: C02KX02

    Manufacturer: Delorbis Pharmaceuticals Ltd. Laboratori Fundació Dau

  • The medicine is used to treat pulmonary arterial hypertension (PAH) in adults, adolescents, and children aged 8 years and older. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood and relieves symptoms such as fatigue, dizziness, or shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    ambrisentan 10 mg

    ATC: C02KX02

    Manufacturer: Delorbis Pharmaceuticals Ltd. Laboratori Fundació Dau

  • The medicine is used to treat pulmonary arterial hypertension (PAH) in adults, adolescents, and children aged 8 years and older. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and relieves symptoms such as fatigue, dizziness, or shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    ambrisentan 5 mg

    ATC: C02KX02

    Manufacturer: Delorbis Pharmaceuticals Ltd. Genepharm S.A.

  • The medicine is used to treat pulmonary hypertension in adults, adolescents, and children aged 8 years and older. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and relieves symptoms such as fatigue, dizziness, or shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    ambrisentan 10 mg

    ATC: C02KX02

    Manufacturer: Delorbis Pharmaceuticals Ltd. Genepharm S.A.